| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5669174 | Journal of Microbiology, Immunology and Infection | 2016 | 4 Pages |
Abstract
We report the in vitro drugs interaction by the resazurin drugs combination microtiter assay (REDCA) of amoxicillin (AMO)/clavulanate (CLAV) with isoniazid (INH), ethambutol (EMB), and rifampicin (RIF) against susceptible and resistant Mycobacterium tuberculosis isolates. The addition of AMO/CLAV to classical antituberculosis drugs should be explored as a promising alternative for the treatment of resistant tuberculosis (TB).
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Aline Daniele Furlan Pagliotto, Katiany Rizzieri Caleffi-Ferracioli, Mariana Aparecida Lopes, Vanessa Pietrowski Baldin, Clarice Queico Fujimura Leite, Fernando Rogério Pavan, Regiane Bertin de Lima Scodro, Vera Lúcia Dias Siqueira,